Sex Differences and Functional Outcome After Intravenous Thrombolysis

© 2017 American Heart Association, Inc..

BACKGROUND AND PURPOSE: Women have a worse outcome after stroke compared with men, although in intravenous thrombolysis (IVT)-treated patients, women seem to benefit more. Besides sex differences, age has also a possible effect on functional outcome. The interaction of sex on the functional outcome in IVT-treated patients in relation to age remains complex. The purpose of this study was to compare outcome after IVT between women and men with regard to age in a large multicenter European cohort reflecting daily clinical practice of acute stroke care.

METHODS: Data were obtained from IVT registries of 12 European tertiary hospitals. The primary outcome was poor functional outcome, defined as a modified Rankin scale score of 3 to 6 at 3 months. We stratified outcome by age in decades. Safety measures were symptomatic intracranial hemorrhage and mortality at 3 months.

RESULTS: In this cohort, 9495 patients were treated with IVT, and 4170 (43.9%) were women with a mean age of 71.9 years. After adjustments for baseline differences, female sex remained associated with poor functional outcome (odds ratio, 1.15; 95% confidence interval, 1.02-1.31). There was no association between sex and functional outcome when data were stratified by age. Symptomatic intracranial hemorrhage rate was similar in both sexes (adjusted odds ratio, 0.93; 95% confidence interval, 0.73-1.19), whereas mortality was lower among women (adjusted odds ratio, 0.83; 95% confidence interval, 0.70-0.99).

CONCLUSIONS: In this large cohort of IVT-treated patients, women more often had poor functional outcome compared with men. This difference was not dependent on age.

Errataetall:

ErratumIn: Stroke. 2017 Mar;48(3):e97. - PMID 28242809

Medienart:

E-Artikel

Erscheinungsjahr:

2017

Erschienen:

2017

Enthalten in:

Zur Gesamtaufnahme - volume:48

Enthalten in:

Stroke - 48(2017), 3 vom: 31. März, Seite 699-703

Sprache:

Englisch

Beteiligte Personen:

Spaander, Fianne H [VerfasserIn]
Zinkstok, Sanne M [VerfasserIn]
Baharoglu, Irem M [VerfasserIn]
Gensicke, Henrik [VerfasserIn]
Polymeris, Alexandros [VerfasserIn]
Traenka, Christopher [VerfasserIn]
Hametner, Christian [VerfasserIn]
Ringleb, Peter [VerfasserIn]
Curtze, Sami [VerfasserIn]
Martinez-Majander, Nicolas [VerfasserIn]
Aarnio, Karoliina [VerfasserIn]
Nolte, Christian H [VerfasserIn]
Scheitz, Jan F [VerfasserIn]
Leys, Didier [VerfasserIn]
Hochart, Anais [VerfasserIn]
Padjen, Visnja [VerfasserIn]
Kägi, Georg [VerfasserIn]
Pezzini, Alessandro [VerfasserIn]
Michel, Patrik [VerfasserIn]
Bill, Olivier [VerfasserIn]
Zini, Andrea [VerfasserIn]
Engelter, Stefan T [VerfasserIn]
Nederkoorn, Paul J [VerfasserIn]
Thrombolysis in Ischemic Stroke Patients Collaborators (TrISP) [VerfasserIn]

Links:

Volltext

Themen:

Age distribution
EC 3.4.21.68
Female
Fibrinolytic Agents
Journal Article
Registries
Research Support, Non-U.S. Gov't
Stroke
Thrombolytic therapy
Tissue Plasminogen Activator

Anmerkungen:

Date Completed 23.05.2017

Date Revised 08.03.2018

published: Print-Electronic

ErratumIn: Stroke. 2017 Mar;48(3):e97. - PMID 28242809

Citation Status MEDLINE

doi:

10.1161/STROKEAHA.116.014739

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM268517444